In patients with increased intracranial pressure, hyperventilation to a PaCO2 of 30–35 mm Hg is limited because it may be associated with which outcome?

In patients with increased intracranial pressure, hyperventilation to a PaCO2 of 30–35 mm Hg is limited because it may be associated with which outcome?

• A. Virtually impossible
• B. Brain ischemia due to a rightward shift of the oxyhemoglobin dissociation curve
• C. May be associated with a worsening of neurologic outcome
• D. Could result in paradoxical cerebral vasodilation

Answer: (C)

Lowering PaCO2 through hyperventilation causes cerebral vasoconstriction, which reduces cerebral blood flow and helps lower intracranial pressure. However, if this vasoconstriction is kept or becomes excessive, cerebral perfusion can fall too much, leading to brain ischemia and potentially worse neurologic outcomes. That risk of worsened neurologic outcome is why hyperventilation to a PaCO2 of 30–35 mm Hg is limited. In this context, the other statements don’t fit: hyperventilation alkalosis shifts the oxyhemoglobin dissociation curve to the left (not right), reducing oxygen release to brain tissue rather than causing vasodilation or being an “impossible” outcome.

Lowering PaCO2 through hyperventilation causes cerebral vasoconstriction, which reduces cerebral blood flow and helps lower intracranial pressure. However, if this vasoconstriction is kept or becomes excessive, cerebral perfusion can fall too much, leading to brain ischemia and potentially worse neurologic outcomes. That risk of worsened neurologic outcome is why hyperventilation to a PaCO2 of 30–35 mm Hg is limited.

In this context, the other statements don’t fit: hyperventilation alkalosis shifts the oxyhemoglobin dissociation curve to the left (not right), reducing oxygen release to brain tissue rather than causing vasodilation or being an “impossible” outcome.